title: Take two: Combining immunotherapy with epigenetic drugs to tackle cancer.
authors.forename: Karen
authors.initials: K
authors.lastname: Weintraub
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001374:Azacitidine / Q000008:administration & dosage; D001549:Benzamides / Q000008:administration & dosage; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D044127:Epigenesis, Genetic; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D008175:Lung Neoplasms / Q000188:drug therapy*; D000077594:Nivolumab; D011725:Pyridines / Q000008:administration & dosage
chemical_list: D000911:Antibodies, Monoclonal; D001549:Benzamides; D011725:Pyridines; C118739:entinostat; D000077594:Nivolumab; D001374:Azacitidine